Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase
Open Access
- 16 November 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 3 (1) , 34-44
Abstract
Plasmodium falciparum (Pf) prolyl-tRNA synthetase (ProRS) is one of the few chemical-genetically validated drug targets for malaria, yet highly selective inhibitors have not been described. In this paper, approximately 40,000 compounds were screened to identify compounds that selectively inhibit PfProRS enzyme activity versus Homo sapiens (Hs) ProRS. X-ray crystallography structures were solved for apo, as well as substrate- and inhibitor-bound forms of PfProRS. We identified two new inhibitors of PfProRS that bind outside the active site. These two allosteric inhibitors showed >100 times specificity for PfProRS compared to HsProRS, demonstrating this class of compounds could overcome the toxicity related to HsProRS inhibition by halofuginone and its analogues. Initial medicinal chemistry was performed on one of the two compounds, guided by the cocrystallography of the compound with PfProRS, and the results can instruct future medicinal chemistry work to optimize these promising new leads for drug development against malaria.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (HHSN272201200025C)
- National Health and Medical Research Council (1042272, 585519)
- Wellcome (100476)
This publication has 30 references indexed in Scilit:
- Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone AntimalarialsCell Host & Microbe, 2013
- Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetaseNature Chemical Biology, 2012
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumCurrent Opinion in Infectious Diseases, 2011
- Chemical genetics of Plasmodium falciparumNature, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D Structural Biology, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Solving structures of protein complexes by molecular replacement withPhaserActa Crystallographica Section D Structural Biology, 2006
- Protein production by auto-induction in high-density shaking culturesProtein Expression and Purification, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004